Show simple item record

dc.contributor.authorLima, Gabrielle Mendespt_BR
dc.contributor.authorQuintans Júnior, Lucindo Josépt_BR
dc.contributor.authorThomazzi, Sara Mariapt_BR
dc.contributor.authorAlmeida, Emyle Mayra Santana Alvespt_BR
dc.contributor.authorMelo, Mônica Santos dept_BR
dc.contributor.authorSerafini, Mairim Russopt_BR
dc.contributor.authorCavalcanti, Sócrates Cabral de Holandapt_BR
dc.contributor.authorGelain, Daniel Penspt_BR
dc.contributor.authorSantos, João Paulo Almeida dospt_BR
dc.contributor.authorBlank, Arie Fitzgeraldpt_BR
dc.contributor.authorAlves, Péricles Barretopt_BR
dc.contributor.authorOliveira Neta, Paulina Marques dept_BR
dc.contributor.authorLima, Julianeli Tolentino dept_BR
dc.contributor.authorRocha, Ricardo Fagundes dapt_BR
dc.contributor.authorMoreira, Jose Claudio Fonsecapt_BR
dc.contributor.authorAraujo, Adriano Antunes de Souzapt_BR
dc.date.accessioned2015-01-13T02:14:46Zpt_BR
dc.date.issued2012pt_BR
dc.identifier.issn0102-695Xpt_BR
dc.identifier.urihttp://hdl.handle.net/10183/108896pt_BR
dc.description.abstractChrysopogon zizanioides (L.) Roberty, Poaceae, is a plant widely used in northeast Brazil in folk medicine for the treatment of various pathological conditions, including infl ammatory pain. The present study evaluated the antinociceptive and antiinfl ammatory effects of C. zizanioides essential oil (EO) in rodents. EO was further characterized by GC/MS. The major components of EO were identifi ed as khusimol (19.57%), E-isovalencenol (13.24%), α-vetivone (5.25%), β-vetivone (4.87%) and hydroxy-valencene (4.64%). Following intraperitoneal injection (i.p.), EO at 50 and 100 mg/kg signifi cantly reduced the number of writhes (51.9 and 64.9%, respectively) and the number of paw licks during phase 2 (56.7 and 86.2%, respectively) of a formalin model when compared to control group animals. However, EO-treated mice were ineffective at all doses in hot-plate and rota-rod tests. The EO inhibited the carrageenan-induced leukocyte migration to the peritoneal cavity in a dose-dependent manner (34.7, 35.4, and 62.5% at doses of 25, 50 and 100 mg/kg, respectively). In the paw edema test, the EO (100 mg/kg) inhibited all three phases of the edema equally well, suggesting that the EO has a non-selective inhibitory effect on the release or actions of these mediators. Our results suggest possible antinociceptive and antiinfl ammatory effects of the EO.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofRevista brasileira de farmacognosia. Vol. 22, n. 2 (mar./abr. 2012), p. 443-450pt_BR
dc.rightsOpen Accessen
dc.subjectPlantas medicinaispt_BR
dc.subjectAnti-inflammatoryeffecten
dc.subjectÓleos essenciaispt_BR
dc.subjectantinociceptive effecten
dc.subjectChrysopogon zizanioidesen
dc.subjectAnti-inflamatóriospt_BR
dc.subjectessential oilen
dc.subjectAnalgésicospt_BR
dc.subjectAnatherum muricatumpt_BR
dc.subjectphytochemical screeningen
dc.subjectvetiveren
dc.titlePhytochemical screening, antinociceptive and anti-inflammatory activities of Chrysopogon zizanioides essential oilpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000914829pt_BR
dc.type.originNacionalpt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record